Katarina Pance

Biotech VC

Professional Overview
Katarina Pance is a seasoned Biotech Venture Capitalist with a track record of driving innovation and growth in the pharmaceutical and biotechnology sectors. With deep expertise in discovery biology and a passion for investing in groundbreaking life sciences technologies, she plays a pivotal role in shaping the future of the industry.

Experience Summary

Current Role
Katarina currently serves as a Biotech VC at SR One Capital Management, where she leverages her scientific acumen and investment savvy to identify and support promising biotech startups. As a Board Observer for Renalys Pharma and Rezo Therapeutics, she provides strategic counsel and guidance to help these companies navigate the complex landscape of drug development and commercialization.

Career Progression
Prior to her venture capital role, Katarina co-founded EpiBiologics, a biotechnology company focused on innovative epigenetic therapeutics. As the Founding Senior Scientist and Head of Discovery Biology, she led the company's research and development efforts, driving advancements in novel drug candidates. Katarina's previous experience includes a Venture Fellow position at MPM Capital and a role as a Life Sciences Consultant at Biotech Connection - Bay Area, Inc., where she honed her expertise in investment analysis and strategic advisory.

Academic Background
Katarina holds a Bachelor of Science degree from the University of Pennsylvania, where she conducted extensive undergraduate research, contributing to advancements in the life sciences field.

Areas of Expertise

• Discovery biology and epigenetic drug development

• Biotech investment analysis and portfolio management

• Scientific and technical due diligence

• Strategic advisory and board-level guidance

• Cross-functional collaboration and team leadership

Professional Impact
Through her work at SR One Capital Management, Katarina has played a pivotal role in identifying and supporting innovative biotech startups poised to transform the pharmaceutical landscape. Her scientific expertise, combined with a keen eye for investment opportunities, has enabled her to contribute to the successful development and commercialization of novel therapies.

Conclusion
Katarina Pance is a versatile Biotech VC with a remarkable blend of scientific expertise and investment acumen. Her proven track record of guiding biotech companies from the earliest stages to commercialization, coupled with her unwavering commitment to advancing the life sciences industry, make her a valuable asset to the organizations she serves.